Key result
Endogenous NO and exogenous NO donors exerted an antithrombotic effect in vivo through direct suppression of platelet aggregation, while eNOS primarily regulated vascular components of thrombosis.
Why the study?
Does NO and eNOS regulation affect vascular and platelet activity during thrombosis in a mouse model?
Does NO and eNOS regulation affect vascular and platelet activity during thrombosis in a mouse model?
Endogenous NO and NO donors directly suppress platelet aggregation, while eNOS primarily regulates the vascular components of thrombosis.
Answers are grounded in this paper and cite their sources.
Differential NO vs eNOS effects in murine thrombosis caution against direct human extrapolation; leaves open distinct platelet-vascular targeting.
Nitric oxide (NO) regulates both vascular tone and platelet function. Since thrombotic diseases and their animal models consist of both vascular and platelet components, the functional mechanisms by which NO and endothelial nitric oxide synthase (eNOS) regulate thrombotic events are unclear. Experiments were conducted by measuring collagen-induced aggregation of freely circulating radio-labelled platelets in the pulmonary vasculature of anaesthetised mice via external detection probes. In addition, cardiac haemodynamic function was assessed by invasive catheterisation during thrombotic stimulation. Platelet aggregation responses were shown to occur independently of changes in vessel tone induced by pharmacological vasoconstriction or vasodilatation. Acute NOS inhibition significantly potentiated the amplitude and duration of platelet aggregation and an NO donor had an inhibitory effect. In contrast, in eNOS-/- mice, the amplitude of platelet aggregation was not affected although the response was protracted following moderate thrombotic stimulation. Thrombosis induced changes in haemodynamic performance were sensitive to vasomodulation and were potentiated by both NOS inhibition and in eNOS-/- mice. In conclusion, endogenous NO and exogenously applied NO donors exert an antithrombotic effect in vivo through a direct suppression of platelet aggregation. In contrast, eNOS exerts a powerful antithrombotic effect upon the vascular components of thrombosis but has a more subtle effect on the duration of thrombotic responses that are platelet-mediated. Our data demonstrate the differential roles of eNOS and general NO bioavailability in regulating vascular and platelet activity during thrombosis.
No takes yet. Share an insight, caveat, or question.
Moore et al. (2010) studied Thrombosis. NOS inhibition and NO donors vs. Control / wild-type was evaluated on Platelet aggregation and cardiac haemodynamic function. Endogenous NO and exogenous NO donors exerted an antithrombotic effect in vivo through direct suppression of platelet aggregation, while eNOS primarily regulated vascular components of thrombosis.
Synapse has enriched 10 related papers. Consider them for comparative context: